• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Negative histology in cervical specimens obtained with the "see and treat" method among women at a referral center in Rio de Janeiro, Brazil: a cross-sectional study.巴西里约热内卢一家转诊中心采用“即见即治”方法获取的宫颈标本组织学检查结果为阴性:一项横断面研究。
BMC Womens Health. 2021 Dec 7;21(1):400. doi: 10.1186/s12905-021-01552-6.
2
Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.通过宫颈管刮术对宫颈细胞学异常女性进行阴道镜检查时诊断宫颈癌前病变
Obstet Gynecol. 2017 Dec;130(6):1218-1225. doi: 10.1097/AOG.0000000000002330.
3
Overtreatment in a see-and-treat approach to cervical intraepithelial lesions.对宫颈上皮内病变的观察与治疗方法中存在过度治疗。
Obstet Gynecol. 2013 Jun;121(6):1209-1216. doi: 10.1097/AOG.0b013e318293ab22.
4
Clinical practice variation and overtreatment risk in women with abnormal cervical cytology in the Netherlands: two-step versus see-and-treat approach.荷兰异常宫颈细胞学女性的临床实践差异和过度治疗风险:两步法与即查即治法。
Am J Obstet Gynecol. 2020 Apr;222(4):354.e1-354.e10. doi: 10.1016/j.ajog.2019.10.004. Epub 2019 Oct 21.
5
Accuracy of endocervical cytological tests in diagnosing preinvasive lesions of the cervical canal in patients with type 3 transformation zone: a retrospective observational study.3型转化区患者宫颈管细胞学检查诊断宫颈管浸润前病变的准确性:一项回顾性观察研究。
Sao Paulo Med J. 2020 Jan-Feb;138(1):47-53. doi: 10.1590/1516-3180.2019.0435.R1.19112019.
6
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.欧洲宫颈癌筛查质量保证指南:宫颈细胞学异常的临床管理建议,第1部分
Cytopathology. 2008 Dec;19(6):342-54. doi: 10.1111/j.1365-2303.2008.00623.x.
7
Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?重复的宫颈 HPV 检测阳性且巴氏涂片未见或仅有轻微细胞学异常。下一步该怎么做?
Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1907-1912. doi: 10.31557/APJCP.2021.22.6.1907.
8
Colposcopy Evaluation at the Time of Loop Electrosurgical Excision Procedure May Avoid Unnecessary Treatment.阴道镜检查在环形电切术时的评估可能避免不必要的治疗。
J Low Genit Tract Dis. 2018 Oct;22(4):367-374. doi: 10.1097/LGT.0000000000000410.
9
Factors Related to Overtreatment in the See-and-Treat Approach: A Retrospective Multicentric Observational Study.与“即诊即治”方法中超治疗相关的因素:一项回顾性多中心观察性研究。
J Low Genit Tract Dis. 2019 Apr;23(2):129-132. doi: 10.1097/LGT.0000000000000455.
10
Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study.美国社区诊所中观察到的阴道镜检查实践:IMPROVE-COLPO 研究的回顾性对照臂。
J Low Genit Tract Dis. 2019 Apr;23(2):110-115. doi: 10.1097/LGT.0000000000000454.

本文引用的文献

1
Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis.支持宫颈上皮内瘤变即查即治管理的证据:系统评价和荟萃分析。
BJOG. 2016 Jan;123(1):59-66. doi: 10.1111/1471-0528.13530. Epub 2015 Jul 14.
2
2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy.2011 年国际宫颈病理和阴道镜学会阴道镜术语。
Obstet Gynecol. 2012 Jul;120(1):166-72. doi: 10.1097/AOG.0b013e318254f90c.
3
Effectiveness of see-and-treat for approaching pre-invasive lesions of uterine cervix.观察与治疗在子宫颈前病变处理中的效果。
Rev Saude Publica. 2009 Oct;43(5):846-50. doi: 10.1590/s0034-89102009000500014.
4
COLPOMICROSCOPIC STUDIES OF THE DISTRIBUTION OF DYSPLASIA AND CARCINOMA IN SITU ON THE EXPOSED PORTION OF THE HUMAN UTERINE CERVIX.
Cancer. 1965 Aug;18:950-4. doi: 10.1002/1097-0142(196508)18:8<950::aid-cncr2820180805>3.0.co;2-t.

巴西里约热内卢一家转诊中心采用“即见即治”方法获取的宫颈标本组织学检查结果为阴性:一项横断面研究。

Negative histology in cervical specimens obtained with the "see and treat" method among women at a referral center in Rio de Janeiro, Brazil: a cross-sectional study.

作者信息

Teodoro Renata Pereira, Scherer Danielle, de Camargo Maria José, da Costa Ana Carolina Carioca, de Andrade Cecília Vianna, Russomano Fábio

机构信息

Woman's Health Care Area, National Institute of Woman's, Child's and Adolescent's Health, Oswaldo Cruz Foundation, Av. Rui Barbosa, 716, Flamengo, Rio de Janeiro, RJ, CEP 22250-020, Brazil.

Clinical Research Unit, National Institute of Woman's, Child's and Adolescent's Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

出版信息

BMC Womens Health. 2021 Dec 7;21(1):400. doi: 10.1186/s12905-021-01552-6.

DOI:10.1186/s12905-021-01552-6
PMID:34876097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8650353/
Abstract

BACKGROUND

According to the Brazilian Guidelines on Cervical Cancer Screening, women with cytopathologic diagnosis of high-grade intraepithelial lesion, abnormal colposcopic findings, fully visible squamocolumnar junction and age 25 years or older should be treated at the first visit ("see and treat-S&T"). The main limitation to this approach is the risk of overtreatment, identified by histology without preinvasive lesion. The objectives of this study were to identify the overtreatment rate in women undergoing S&T in cervical cancer prevention at a referral center with extensive experience with the method and to detect possible factors associated with this rate.

METHODS

This was a cross-sectional study that analyzed records from a database with 616 women submitted to S&T from 1996 to 2017. Negative histology was defined as the following histopathologic results: human papillomavirus without cervical intraepithelial neoplasia (CIN), inflammatory, low-grade squamous intraepithelial lesion, and CIN 1.

RESULTS

Of the 616 women, there were 52 (8.44%, 95%CI 6.25-10.64%) with a histopathologic report without preinvasive cervical lesion. No statistical association was found between this outcome and age or a significant downward trend over time.

CONCLUSION

The overtreatment rate in this study can be considered low and consistent with the acceptable rates reported in the literature, reinforcing the prevailing Brazilian guideline, in which the benefits of immediate treatment outweigh the risk of losses following biopsy.

摘要

背景

根据巴西宫颈癌筛查指南,细胞病理学诊断为高级别上皮内病变、阴道镜检查结果异常、鳞柱交界完全可见且年龄在25岁及以上的女性应在首次就诊时接受治疗(“即见即治-S&T”)。这种方法的主要局限性是过度治疗的风险,这可通过无浸润前病变的组织学检查来确定。本研究的目的是在一个对该方法有丰富经验的转诊中心,确定接受S&T的宫颈癌预防女性中的过度治疗率,并检测与此率相关的可能因素。

方法

这是一项横断面研究,分析了一个数据库中的记录,该数据库包含1996年至2017年接受S&T的616名女性。阴性组织学定义为以下组织病理学结果:无宫颈上皮内瘤变(CIN)的人乳头瘤病毒、炎症、低级别鳞状上皮内病变和CIN 1。

结果

在616名女性中,有52名(8.44%,95%CI 6.25-10.64%)的组织病理学报告显示无宫颈浸润前病变。未发现该结果与年龄之间存在统计学关联,也未发现随时间有显著的下降趋势。

结论

本研究中的过度治疗率可被认为较低,与文献报道的可接受率一致,这强化了现行的巴西指南,即立即治疗的益处超过活检后漏诊的风险。